Gladstone Institutional Advisory LLC Novo Cure LTD Transaction History

Gladstone Institutional Advisory LLC

  • $2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$116.17 - $194.55 $182,967 - $306,416
-1,575 Closed
0 $0
Q2 2021

Jan 27, 2023
SELL
$130.4 - $225.58 $3,260 - $5,639
-25 Reduced 1.56%
1,575 $349,000
Q2 2021

Aug 13, 2021
SELL
$130.4 - $225.58 $3,260 - $5,639
-25 Reduced 1.56%
1,575 $349,000
Q4 2020

Jan 27, 2023
BUY
$112.16 - $174.14 $179,456 - $278,624
1,600 New
1,600 $277,000
Q4 2020

Feb 16, 2021
BUY
$112.16 - $174.14 $179,456 - $278,624
1,600 New
1,600 $277,000

Others Institutions Holding NVCR

# of Institutions
262
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.03B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email